Related Experiment Video
Updated: Aug 12, 2026
10:51
Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
Published on: January 20, 2012
Orbitofrontal Cortex: A 'Non-rewarding' New Treatment Target in Depression?
1Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada; Krembil Research Institute, University Health Network, Toronto, Canada; Centre for Mental Health, University Health Network, Toronto, Canada; MRI-Guided rTMS Clinic, Poul Hansen Centre for Depression, University Health Network, Toronto, Canada.
Current Biology : CB
|January 23, 2019
Summary
Self-perpetuating activity in the lateral orbitofrontal cortex may sustain depression. Disrupting this activity rapidly improved mood, suggesting new treatment avenues for mood disorders.
Area of Science:
- Neuroscience
- Psychiatry
- Cognitive Science
Background:
- Recurrent negative thoughts and emotions are hallmarks of depression.
- The lateral orbitofrontal cortex (lOFC) is implicated in sustaining these mood states.
- Understanding the neural mechanisms of self-perpetuating activity is crucial for developing effective depression treatments.
Purpose of the Study:
- To investigate the role of self-perpetuating activity in the lateral orbitofrontal cortex (lOFC) in maintaining depressive symptoms.
- To determine if disrupting lOFC activity can lead to rapid mood improvements.
Main Methods:
- Utilized neuroimaging techniques to identify and measure self-perpetuating activity in the lOFC.
- Employed a targeted intervention to modulate activity within the lOFC.
- Assessed changes in mood state and depressive symptoms following the intervention.
Main Results:
- Confirmed self-perpetuating activity in the lOFC in individuals with depression.
- Demonstrated that disruption of this activity led to significant and rapid improvements in mood.
- Observed a correlation between the degree of activity disruption and the magnitude of mood improvement.
Conclusions:
- Self-perpetuating activity in the lOFC is a key mechanism sustaining depression.
- Targeted disruption of lOFC activity offers a promising novel therapeutic strategy for rapid mood improvement.
- Further research into neuromodulation techniques for depression is warranted.
More Related Videos
Related Concept Videos
01:21Association Areas of the Cortex
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...